RES-701-1, comparative study of the synthetic and the microbial-origin compounds
- 3 August 1995
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 5 (15) , 1595-1600
- https://doi.org/10.1016/0960-894x(95)00264-t
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- RES-701-1, a novel and selective endothelin type B receptor antagonist produced by Streptomyces sp. RE-701. II. Determination of the primary sequence.The Journal of Antibiotics, 1994
- RES-701-1,a novel and selective endothelin type B receptor antagonist produced by Streptomyces sp. RE-701. I. Characterization of producing strain, fermentation, isolation, physico-chemical and biological properties.The Journal of Antibiotics, 1994
- Cloning and expression of human endothelin‐1 receptor cDNAFEBS Letters, 1991
- Molecular cloning of a non-isopeptide-selective human endothelin receptorBiochemical and Biophysical Research Communications, 1991
- 2‐Chlorotrityl chloride resinInternational Journal of Peptide and Protein Research, 1991
- Cloning and sequence analysis of a cDNA encoding human non-selective type of endothelin receptorBiochemical and Biophysical Research Communications, 1991
- Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptorNature, 1990
- Cloning and expression of a cDNA encoding an endothelin receptorNature, 1990
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988
- Improved spectral resolution in COSY 1H NMR spectra of proteins via double quantum filteringBiochemical and Biophysical Research Communications, 1983